SG

Swamithayumanavar Gnanasundaram

Active Director Managing Director DIN 10194666
DIN 10194666 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Swamithayumanavar Gnanasundaram

Data last updated:

Swamithayumanavar Gnanasundaram is a Managing Director at Trigenix Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10194666
Primary Designation Managing Director
Industry Pharma
First Appointment 07 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director07 Jun 20232023Active

Board colleagues of Swamithayumanavar Gnanasundaram

Directorship timeline

Open interactive timeline →
Trigenix Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Swamithayumanavar Gnanasundaram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swamithayumanavar Gnanasundaram

Swamithayumanavar Gnanasundaram currently holds 1 directorship: Trigenix Pharmaceutical Private Limited (Managing Director, since 07 Jun 2023).

Swamithayumanavar Gnanasundaram was first appointed on 07 Jun 2023 as Managing Director at Trigenix Pharmaceutical Private Limited.

The current boards of Swamithayumanavar Gnanasundaram's companies include Mayakrishnan Vijayalakshmi (Trigenix Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available